These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 19747435

  • 21. [Effect of Fagopyrum cymosum (Trev.) Meisn alcohol extract on defecation and isolated colon of diarrhea-IBS rats and its mechanism].
    Liu LN, Yan J, Sun ZG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1469-75. PubMed ID: 25632748
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
    Ji L, Zhao X, Zhang Y, Zhao P, Gong R, Li F, Huang H.
    Medicine (Baltimore); 2022 Mar 04; 101(9):e28895. PubMed ID: 35244043
    [Abstract] [Full Text] [Related]

  • 23. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
    Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K.
    Clin Gastroenterol Hepatol; 2014 Jun 04; 12(6):953-9.e4. PubMed ID: 24315882
    [Abstract] [Full Text] [Related]

  • 24. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB, Han M, Cheng HJ, Zhang QY, Zhang NW, Jia BY, Robinson N, Liu JP.
    Trials; 2022 Mar 21; 23(1):226. PubMed ID: 35313933
    [Abstract] [Full Text] [Related]

  • 25. Tongxie Formula Reduces Symptoms of Irritable Bowel Syndrome.
    Fan H, Zheng L, Lai Y, Lu W, Yan Z, Xiao Q, Li B, Tang M, Huang D, Wang Y, Li Z, Mei Y, Jiang Z, Liu X, Tang Q, Zuo D, Ye J, Yang Y, Huang H, Tang Z, Xiao J, China Irritable Bowel Syndrome Consortium.
    Clin Gastroenterol Hepatol; 2017 Nov 21; 15(11):1724-1732. PubMed ID: 28634136
    [Abstract] [Full Text] [Related]

  • 26. [Efficacy and mechanism of acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome of liver depression and spleen deficiency].
    Wang SS, Wang XR, Yang RY, Xu Y, Li MY.
    Zhongguo Zhen Jiu; 2020 Jun 12; 40(6):605-9. PubMed ID: 32538010
    [Abstract] [Full Text] [Related]

  • 27. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial.
    Zheng L, Lai Y, Lu W, Li B, Fan H, Yan Z, Gong C, Wan X, Wu J, Huang D, Wang Y, Mei Y, Li Z, Jiang Z, Liu X, Ye J, Yang Y, Huang H, Xiao J.
    Clin Gastroenterol Hepatol; 2015 Jul 12; 13(7):1285-1292.e1. PubMed ID: 25632806
    [Abstract] [Full Text] [Related]

  • 28. [Comparative observation on therapeutic effects between acupuncture and western medication for diarrhea-predominant irritable bowel syndrome].
    Li H, Pei LX, Zhou JL.
    Zhongguo Zhen Jiu; 2012 Aug 12; 32(8):679-82. PubMed ID: 23072079
    [Abstract] [Full Text] [Related]

  • 29. [Shen warming Pi strengthening method intervened IBS-D rats: an efficacy assessment].
    Su XL, Tang YP, Zhang J, Bai YB, Shi HX, Liu YJ, Chang YJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb 12; 34(2):197-202. PubMed ID: 24672945
    [Abstract] [Full Text] [Related]

  • 30. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
    Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J.
    Arq Gastroenterol; 2013 Feb 12; 50(4):304-9. PubMed ID: 24474234
    [Abstract] [Full Text] [Related]

  • 31. Lipi Guben decoction in treating diarrheal irritable bowel syndrome: A study protocol for a randomized controlled trial.
    Yang H, Liu X, Peng W, Chen R, Chen Y.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e23887. PubMed ID: 33545956
    [Abstract] [Full Text] [Related]

  • 32. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M, Tang TC, Wang Y, Shui J, Xiao XH, Lan X, Yu P, Zhang C, Wang SH, Yao J, Zheng H, Huang DQ.
    Aliment Pharmacol Ther; 2018 Jul 22; 48(2):160-168. PubMed ID: 29856472
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H.
    Neurogastroenterol Motil; 2015 May 22; 27(5):705-16. PubMed ID: 25809913
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y, Huang YQ, Zhu SL, Zhang CR, Chen XL, Hou QK, Liu FB.
    Trials; 2020 Nov 03; 21(1):908. PubMed ID: 33143731
    [Abstract] [Full Text] [Related]

  • 35. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS, Tsai CH, Li TC, Lai HC, Wang KT, Liao WL, Hsieh CL.
    J Ethnopharmacol; 2019 Jun 28; 238():111889. PubMed ID: 31009707
    [Abstract] [Full Text] [Related]

  • 36. [Open, multicenter, phase Ⅳ clinical trial of Shenbei Guchang capsules in treatment of diarrhea type irritable bowel syndrome].
    Qiu CH, Li LP, Zhang CM, Liu CS, Liang T, Jian Y, Wang HB, Zhang Y, Wang GS, Xie XX, Chen SA, He WM, Zhang X, Jiang YS, Liao J, Chen D, Liu B, Pan WB.
    Zhongguo Zhong Yao Za Zhi; 2016 May 28; 41(10):1947-1951. PubMed ID: 28895348
    [Abstract] [Full Text] [Related]

  • 37. Xiaoyao-san, a traditional Chinese herbal formula, for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.
    Lee J, Sung WS, Kim EJ, Kim YW.
    Medicine (Baltimore); 2021 Mar 12; 100(10):e24019. PubMed ID: 33725813
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q, Zhang BP, Huang SG, Ouyang WW, Xie JH, Wen ZH, Yang XB.
    Trials; 2018 Jul 11; 19(1):367. PubMed ID: 29996882
    [Abstract] [Full Text] [Related]

  • 39. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 40. [Treating irritable bowel syndrome by wuling capsule combined pinaverium bromide: a clinical research].
    Wu XW, Hou Y, Ji HZ, Liang MM, Xu LE, Wang FY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Apr 15; 35(4):415-8. PubMed ID: 26043562
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.